# Cytokine and Chemokine-Associated Signatures Underlying Dermal Invasion and Skin Metastasis in Melanoma

**Authors:** Viktória Koroknai, István Szász, Tünde Várvölgyi, Gabriella Emri, Ádám Fodor, Margit Balázs

PMC · DOI: 10.3390/ijms26199334 · 2025-09-24

## TL;DR

This study explores how cytokines and chemokines influence melanoma's spread to the skin, identifying key molecules involved in dermal invasion and metastasis.

## Contribution

The study identifies cytokine and chemokine signatures associated with melanoma dermal invasion and skin metastasis.

## Key findings

- Co-culture experiments revealed altered expression of cytokine receptor genes like CCR5 and CXCR7.
- IL1RAPL2 and TNFRSF10A were significantly downregulated in cutaneous metastases.
- Midkine levels were elevated in plasma of patients with skin metastases.

## Abstract

Metastatic spread remains the primary cause of mortality in melanoma. Our aim was to investigate the role of dermal endothelial cells in modulating melanoma cell invasiveness and cytokine/chemokine pattern. Primary melanoma cell lines were co-cultured with human dermal endothelial cells and assessed using Matrigel invasion assays. Invasive and non-invasive subpopulations were separated for gene expression analyses, and candidate molecules were further evaluated in patient tissue and plasma samples. Co-culture of melanoma and dermal endothelial cells revealed altered expression of several cytokine receptor genes (CCR5, CXCR7, IL1RAPL2, IL4R, IL6ST, IL18R1, IL22RA2, TNFRSF10A, TNFRSF11B, and TNFRSF21). Analysis of clinical melanoma samples showed significant downregulation of IL1RAPL2 and TNFRSF10A in cutaneous metastases, whereas IL6ST expression correlated with Breslow thickness of the primary tumor rather than metastatic site. Proteome profiling of dermal endothelial cells revealed alterations in Midkine, GROα, MIP-3α, IL-8, and SDF-1 following co-culture with melanoma cells. Plasma measurements in melanoma patients confirmed elevated Midkine levels in skin metastases and decreased MIP-3α in metastatic disease. These results highlight potential cytokine and chemokine-mediated pathways involved in melanoma dermal invasion and cutaneous metastasis. While some findings did not reach statistical significance, concordant trends between in vitro and patient-derived data suggest their relevance and warrant further investigation in larger cohorts.

## Linked entities

- **Genes:** CCR5 (C-C motif chemokine receptor 5) [NCBI Gene 1234], ACKR3 (atypical chemokine receptor 3) [NCBI Gene 57007], IL1RAPL2 (interleukin 1 receptor accessory protein like 2) [NCBI Gene 26280], IL4R (interleukin 4 receptor) [NCBI Gene 3566], IL6ST (interleukin 6 cytokine family signal transducer) [NCBI Gene 3572], IL18R1 (interleukin 18 receptor 1) [NCBI Gene 8809], IL22RA2 (interleukin 22 receptor subunit alpha 2) [NCBI Gene 116379], TNFRSF10A (TNF receptor superfamily member 10a) [NCBI Gene 8797], TNFRSF11B (TNF receptor superfamily member 11b) [NCBI Gene 4982], TNFRSF21 (TNF receptor superfamily member 21) [NCBI Gene 27242]
- **Proteins:** mdk.S (midkine S homeolog), CXCL1 (C-X-C motif chemokine ligand 1), CCL20 (C-C motif chemokine ligand 20), CXCL8 (C-X-C motif chemokine ligand 8), CXCL12 (C-X-C motif chemokine ligand 12)
- **Diseases:** melanoma (MONDO:0005105)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** IL22RA2 (interleukin 22 receptor subunit alpha 2) [NCBI Gene 116379] {aka CRF2-10, CRF2-S1, CRF2X, IL-22BP, IL-22R-alpha-2, IL-22RA2}, IL1RAPL2 (interleukin 1 receptor accessory protein like 2) [NCBI Gene 26280] {aka IL-1R9, IL1R9, IL1RAPL-2, TIGIRR-1}, IL6ST (interleukin 6 cytokine family signal transducer) [NCBI Gene 3572] {aka CD130, CDW130, GP130, HIES4, HIES4A, HIES4B}, TNFRSF11B (TNF receptor superfamily member 11b) [NCBI Gene 4982] {aka OCIF, OPG, PDB5, TR1}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, IL18R1 (interleukin 18 receptor 1) [NCBI Gene 8809] {aka CD218a, CDw218a, IL-18R, IL-18R-alpha, IL-18Ralpha, IL-1Rrp}, ACKR3 (atypical chemokine receptor 3) [NCBI Gene 57007] {aka CMKOR1, CXC-R7, CXCR-7, CXCR7, GPR159, RDC-1}, TNFRSF10A (TNF receptor superfamily member 10a) [NCBI Gene 8797] {aka APO2, CD261, DR4, TRAILR-1, TRAILR1}, CXCL1 (C-X-C motif chemokine ligand 1) [NCBI Gene 2919] {aka FSP, GRO1, GROa, MGSA, MGSA-a, NAP-3}, IL4R (interleukin 4 receptor) [NCBI Gene 3566] {aka CD124, IL-4RA, IL4RA}, CCL20 (C-C motif chemokine ligand 20) [NCBI Gene 6364] {aka CKb4, Exodus, LARC, MIP-3-alpha, MIP-3a, MIP3A}, CXCL12 (C-X-C motif chemokine ligand 12) [NCBI Gene 6387] {aka IRH, PBSF, SCYB12, SDF1, TLSF, TPAR1}, TNFRSF21 (TNF receptor superfamily member 21) [NCBI Gene 27242] {aka BM-018, CD358, DR6}, MDK (midkine) [NCBI Gene 4192] {aka ARAP, MK, NEGF2}, CCR5 (C-C motif chemokine receptor 5) [NCBI Gene 1234] {aka CC-CKR-5, CCCKR5, CCR-5, CD195, CKR-5, CKR5}
- **Diseases:** Melanoma (MESH:D008545), Metastasis (MESH:D009362), tumor (MESH:D009369), cutaneous (MESH:D018366)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12524697/full.md

---
Source: https://tomesphere.com/paper/PMC12524697